[Abstract] Over the past 15 years, the free-living nematode, Caenorhabditis elegans has become an important model system for exploring eukaryotic innate immunity to bacterial and fungal pathogens.
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Note: Confluency can affect VSV titers and the optimal confluency to initiate infection is when cells cover 80-90% of the plate surface.
2. The following day, dilute starter VSV stock into 20 ml of DMEM with the appropriate volume (dependent upon titer of starting stock) to achieve a multiplicity of infection (MOI) of 0.01 using 5 ml of this VSV-DMEM mixture per dish for infection. For example, assuming a cell doubling time of ~24 h (producing a total cell number of 1 x 10 7 /dish), 1 x 10 5 PFU would be needed per 5 ml of DMEM for infection of each dish.
3. Incubate cells at 37 °C with 5% CO2 for 2 h, rocking every 30 min to spread the inocula evenly across the dish.
4. 2 h post-infection (hpi) replace inocula with 25 ml of complete DMEM (see Recipes).
www.bio-protocol.org/e2617 5. After 24-36 hpi, when significant cytopathic effect has been observed such that ~50% of the cell monolayer has lifted off the plate and cells have become rounded in appearance (Figure 1 ), collect supernatants from infected cultures and place in 50 ml conical tubes.
Figure 1. BHK cell culture before (A and C) and after ~30 h of VSV infection (B and D)
6. Spin harvested supernatants in a benchtop centrifuge with a swinging bucket rotor at 1,000 x g for 10 min at 4 °C to pellet cells.
7. Transfer equal volumes of cleared supernatants (~25 ml/each) to Beckman Ultra-Clear ultracentrifuge tubes and place tubes in an SW28 swinging bucket rotor.
8. Pellet virus particles by ultracentrifugation at 25,000 rpm (~50,000 x g) for 2 h at 4 °C. Pellets should be observable at the bottom of each tube after ultracentrifugation.
9. Aspirate supernatants and resuspend virus particles in 0.5 ml or less DMEM.
10. Aliquot 10 µl of concentrated VSV stock into cryovials and freeze at -80 °C. 2. Slide the capillary tube through the filament ring using the grooves as a guide, being careful not to disturb the filament itself.
3. Position the tube so the filament is halfway down then tighten the knobs on either side of the filament to hold the capillary tube in place ( Figure 2A ). 6. Carefully wrap a cover glass in cloth or paper towel and gently bend the glass until it breaks.
Ideally, break a 50 mm cover glass into 4-6 fragments.
7. Place a fragment of a broken coverslip on top of a second coverslip with a drop of microinjection oil to keep the broken piece in place ( Figure 2C ).
8. Place the coverslip on the stage and bring the edge of the glass fragment into focus using the 5x objective.
9. Bring the needle into focus next to the glass fragment edge and switch to the 40x objective ( Figure 2D ).
10. Refocus if necessary and gently push the needle against the side of the glass fragment. Once the needle tip bends slightly ( Figure 2E ) and vibrates against the glass, pull it away and inject a small amount of air into the oil. An air bubble confirms the tip has been broken open ( Figure 2F ).
D. Preparation of test animals
1. Synchronize worms (N2 and test animals) in the L1 stage using bleach solution (see Recipes) as described (He, 2011b ).
3. Centrifuge injection mixture at 5,000 x g at 4 °C for 10 min to pellet any particulates that could clog the needle. Transfer 20 µl of supernatant to a new 1.5 ml tube to use as injection media.
Note: DMEM lacking VSV is used for mock-infection media, which serves as a negative control
for infection.
4. Lightly soak a Kimwipe with water, fold it into a strip and tape it to the inside of the needleholding Petri dish to maintain humidity. mm Petri dish that also contains a dampened Kimwipe to maintain humidity.
F. Microinjection of virus media

Note: Because microinjection is a procedure that takes time to master, we suggest practicing by injecting worms with virus-free DMEM and ensuring that the vast majority (> 80%) of injected worms
survive the next day before proceeding with VSV injections.
1. Dip a pipette tip in microinjection oil and spread a very thin layer of oil across the agarose pad of a coverslip.
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3. On a dissecting stereoscope, transfer one to several worms from their NGM plate to the agarose pad using a worm pick.
Note: To do so easily, first touch the pick to the microinjection oil, then use the oil to help pick up the worms using the bottom of your pick. Minimize the transfer of bacteria from the plate to the pad.
4. Use the pick to gently orient the worms all into a row where all the worms are facing the same direction.
5. Transfer the slide to the microinjection scope and focus the worms using the 5x objective. Raise the level of focus to slightly above the worms, then use the manipulator to position the needle until its tip is in focus, right above the worms.
6. Switch to the 40x objective, re-focus on the worms and then lower the needle into the field of view. The needle tip should be in focus next to the worm, at the focal plane where the worm is the widest. . We typically incubate infected worms at 25 °C to achieve higher rates of virus replication .
G. Scoring infection using fluorescence assay (after injection with VSV-dsRED)
Note: Worms injected with virus-free DMEM serve as a negative control group for infection in this experiment. These animals can be used to ensure fluorescence observed in VSV-dsRED-injected
animals is not an artifact. 1. At specific intervals post-infection (typically 24-72 hpi), worms should be harvested from each treatment to score for luciferase activity, which is used as a readout for VSV-LUC replication (Gammon et al., 2014 and Figure 6A ). Unpaired Student's t-tests can be used to compare the maximum infection rates between two strains (e.g., N2 vs.
drh-1) as described Figure 6B ) to estimate the lifespan of the animals (from time of microinjection until death). 
